Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 28, 2018

Total Value: $171M (100.0% shares, 0.0% debt)

Holdings (31)

— AMARIN CORP PLC -ADR 14.3%
Value $24.41M Shares 1,500,000 Share Price $16.27 Est. Cost/Share $3.01 Unrealized @ Report Date —
— APOLLO ENDOSURGERY INC 10.8%
Value $18.48M Shares 2,577,996 Share Price $7.17 Est. Cost/Share $4.75 Unrealized @ Report Date —
— BIOSPECIFICS TECHNOLOGIES 9.8%
Value $16.68M Shares 285,259 Share Price $58.49 Est. Cost/Share $45.13 Unrealized @ Report Date —
— BIODELIVERY SCIENCES INTL 7.1%
Value $12.07M Shares 4,311,103 Share Price $2.80 Est. Cost/Share $2.54 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 6.7%
Value $11.45M Shares 5,302,063 Share Price $2.16 Est. Cost/Share $3.25 Unrealized @ Report Date —
— VIVEVE MEDICAL INC 6.0%
Value $10.32M Shares 3,849,711 Share Price $2.68 Est. Cost/Share $6.92 Unrealized @ Report Date —
— MELINTA THERAPEUTICS INC 4.5%
Value $7.736M Shares 1,958,595 Share Price $3.95 Est. Cost/Share $4.01 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 4.4%
Value $7.45M Shares 324,600 Share Price $22.95 * Est. Cost/Share $14.90 Unrealized @ Report Date +37.0%
CPIX CUMBERLAND PHARMACEUTICALS 4.1%
Value $6.957M Shares 1,218,401 Share Price $5.71 * Est. Cost/Share $5.83 Unrealized @ Report Date +1.1%
— ALIMERA SCIENCES INC 4.0%
Value $6.848M Shares 6,987,856 Share Price $0.98 Est. Cost/Share $1.18 Unrealized @ Report Date —
— OPHTHOTECH CORP 3.2%
Value $5.486M Shares 2,324,782 Share Price $2.36 Est. Cost/Share $3.80 Unrealized @ Report Date —
— NOVELION THERAPEUTICS INC 3.0%
Value $5.118M Shares 1,728,887 Share Price $2.96 Est. Cost/Share $8.14 Unrealized @ Report Date —
— OXFORD IMMUNOTEC GLOBAL PLC 2.1%
Value $3.666M Shares 225,877 Share Price $16.23 Est. Cost/Share $16.23 Unrealized @ Report Date —
— CORREVIO PHARMA CORP 2.1%
Value $3.611M Shares 898,157 Share Price $4.02 Est. Cost/Share $3.78 Unrealized @ Report Date —
— OPIANT PHARMACEUTICALS INC 1.9%
Value $3.32M Shares 185,887 Share Price $17.86 Est. Cost/Share $17.86 Unrealized @ Report Date —
— FOAMIX PHARMACEUTICALS LTD 1.8%
Value $3.158M Shares 551,078 Share Price $5.73 Est. Cost/Share $5.73 Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 1.8%
Value $3.053M Shares 138,100 Share Price $22.11 * Est. Cost/Share $13.52 Unrealized @ Report Date 0.0%
— CIDARA THERAPEUTICS INC 1.7%
Value $2.887M Shares 656,148 Share Price $4.40 Est. Cost/Share $4.92 Unrealized @ Report Date —
— HTG MOLECULAR DIAGNOSTICS 1.6%
Value $2.705M Shares 535,590 Share Price $5.05 Est. Cost/Share $3.26 Unrealized @ Report Date —
ATEC ALPHATEC HOLDINGS INC 1.5%
Value $2.533M Shares 751,756 Share Price $3.37 * Est. Cost/Share $3.55 Unrealized @ Report Date -11.2%
SPRO SPERO THERAPEUTICS INC 1.4%
Value $2.38M Shares 226,444 Share Price $10.51 * Est. Cost/Share $11.61 Unrealized @ Report Date 0.0%
— MOLECULAR TEMPLATES INC 1.2%
Value $2.039M Shares 378,295 Share Price $5.39 Est. Cost/Share $5.39 Unrealized @ Report Date —
ALDX ALDEYRA THERAPEUTICS INC 1.2%
Value $2.001M Shares 145,000 Share Price $13.80 * Est. Cost/Share $8.11 Unrealized @ Report Date 0.0%
— CATABASIS PHARMACEUTICALS IN 1.0%
Value $1.733M Shares 2,166,154 Share Price $0.80 Est. Cost/Share $0.96 Unrealized @ Report Date —
XENE XENON PHARMACEUTICALS INC 0.8%
Value $1.32M Shares 100,000 Share Price $13.20 * Est. Cost/Share $11.59 Unrealized @ Report Date 0.0%
— NEOS THERAPEUTICS INC 0.6%
Value $1.105M Shares 227,919 Share Price $4.85 Est. Cost/Share $4.85 Unrealized @ Report Date —
— SPRING BANK PHARMACEUTICALS 0.5%
Value $856K Shares 71,050 Share Price $12.05 Est. Cost/Share $12.05 Unrealized @ Report Date —
— CANCER GENETICS INC 0.4%
Value $639K Shares 614,411 Share Price $1.04 Est. Cost/Share $1.85 Unrealized @ Report Date —
— SCYNEXIS INC 0.3%
Value $539K Shares 448,777 Share Price $1.20 Est. Cost/Share $1.20 Unrealized @ Report Date —
SRTS SENSUS HEALTHCARE INC 0.2%
Value $317K Shares 37,858 Share Price $8.37 * Est. Cost/Share $7.24 Unrealized @ Report Date 0.0%
— DOVA PHARMACEUTICALS INC 0.1%
Value $145K Shares 6,900 Share Price $21.01 Est. Cost/Share $21.01 Unrealized @ Report Date —